1[1]Essais D, Bouguerra R, Hamzaoui J, et al. Efficacy and safety of BRC in the treatment of macroprolactinemia. Ann Endocrinol, 2002,63:524-531.
2[2]Corsello SM, Ubertini G, Altomare M, et al. Giant prolactinomas in men: efficacy of CAB treatment. Clin Endocrinol, 2003, 58:662-670.
3[3]Colao A, Ferone D, Marzullo P, et al. Effects of different dopaminergic agents in the treatment of acromegaly. J Clin Endocrinol Metab,1997, 82:518-523.
4[4]Abs R, Verhelst J, Maiter D, et al. Cabergoline in the treatment of acromegaly: a study in 64 patients. J Clin Endocrinol Metab, 1998,83:374-378.
5[5]Attanasio R, Barausse M, Cozzi R. GH/IGF- I normolization and tumor shrinkage during long-term treatment of acromegaly by lanreotide. J Endocrinol Invest, 2001, 24:209-216.
6[6]Ambrosio MR, Franceschetti P, Bondanelli M, et al. Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly. Metabolism, 2002,51:387-393.
7[7]Van der Lely AJ, Hutson RK, Trainer PJ, et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet, 2001, 358:1754-1759.
5Hoybye C, Grenbaek E, Rahn T, et al. Adrenocortieotmpic hormone-producing pituitary tumors: 12-to-22 year follow-up after treatment with stereo-tactieradio- surgery[J]. Neurosurg, 2001,49(2) : 284-292.
6Tatsuya K, Yoshihisa K, Yoshimasa M. Gamma knife radiosurgery in the treat-ment of Cushing disease, long- term results[J]. Neurosurg, 2002,97 (5) : 422 -428.
7Morange-Ramos I, Regis J,Dufour H, et al. Short term endocrinological re-suhs after gamma knife surgery of pituitary adenomas [J]. Stereotact Funct Neurosurg, 1998,70(1) : 127- 138.
9Izawa M, Hayashi M, Nakaya K, et al. Gamma knife radiosurgery for pituitary adenomas [J]. Neurosurg (Suppl 3), 2000,93 : 19-22.
10Attanasio R, Epaminonda P, Motti E, et al. Gamma knife radiosurgery in acro- megaly: a 4- year follow- up study[J]. Clin Endocrinol Metab,2003,88(7):3105-3112.
